Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells
about
Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of ActionUrokinase receptor and resistance to targeted anticancer agentsEpithelial-mesenchymal plasticity in carcinoma metastasisHER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast canceruPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages.Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cellsAnalysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties.A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.uPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in gliomainitiating cells.Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogenBasal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.Role of urokinase receptor in tumor progression and development.The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single targetForkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5.In vitro three-dimensional (3D) models in cancer research: an update.Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.Transcriptomic pathway analysis of urokinase receptor silenced breast cancer cells: a microarray study.Transforming growth factor-beta signaling leads to uPA/PAI-1 activation and metastasis: a study on human breast cancer tissues.D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.
P2860
Q26766956-5C65065A-341D-47D6-8EE4-306C9140167AQ26797385-0BC6972B-7C7C-4800-A047-13FE2E061210Q26859804-9FA76AFA-E0FC-4B9C-83A7-85F2BF085D0CQ28085413-831C4905-5778-438A-8F53-02951698225AQ30249137-41B888DE-592E-45A0-B099-A8BB21312EAFQ30365899-7E497995-73BE-4B04-8FCB-930DFB4F809FQ33853018-0CB9C61D-772D-4BB9-8440-E0A7952BEBDFQ34140296-95DD7083-DACB-45ED-9983-7AB011762CE0Q34979703-32638F6C-CE0D-4921-9626-04247371A4A5Q35029475-D7685B44-029F-44DA-956B-7AC079C76C35Q36010145-B4B1E1B7-B89F-4B9A-86B3-16AA5BE96A68Q36016967-6C0CA862-5225-4F2D-B830-B9D0779B7318Q36059078-3E9030C8-F00A-4ADD-9E51-0E86520DF226Q36618624-37DD4F50-D688-453D-9CB6-17127B10A358Q36740700-AA7D3D42-86DB-4842-939C-B2A1E2A68A97Q36746291-A4575410-4B33-48F4-8788-29F70C381640Q36997616-4A1E3767-AF13-4140-B8C0-153C9328F8B4Q36997621-29A2425D-50AD-4C05-932A-32694D48AB70Q37034369-0D77E986-3374-4B72-9C79-A7381C9232C2Q37079634-3140A68F-43B7-49EE-AFCC-27E08B0FC1A4Q37702577-B1B6D5D9-9D49-4A3D-95C9-09BC81E8F0DCQ37709042-FAE6044F-C08D-4515-9621-C48FD3B099A3Q37967634-6DF14B2F-465F-4DA0-A71E-6FDC92F46A49Q38132176-3E41F986-0ABD-40AE-8D01-2D1F36B06667Q39393642-8B283CCF-391C-44A7-91D4-53AF4A3ED127Q39424688-6DF6A03D-90B2-4468-8AB2-18846FDADA59Q39443785-F7553A3E-10B0-4C9A-ABCA-4AFAA07817DAQ42085614-8B3C2DEC-F068-48C6-866C-ECB4F5E49815Q47126059-D06F200C-08C1-4066-9ED9-D0C8AF87D470Q47604922-47D8B1EA-47DB-48CF-891B-A9C85E38C7FCQ48220228-81CA5104-439F-48CE-ACCD-CBE8E23AD462Q50138615-39458C03-B01D-4F66-9A87-AA763EC7A7BFQ50201202-05E9EF31-43E4-4ECD-BFC8-1E873A7E2FF2
P2860
Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@ast
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@en
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@nl
type
label
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@ast
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@en
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@nl
prefLabel
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@ast
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@en
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@nl
P2093
P2860
P1433
P1476
Cell signaling by urokinase-ty ...... perties in breast cancer cells
@en
P2093
Boryana M Eastman
Drue L Webb
Konstantin Stoletov
Richard Klemke
Steven L Gonias
P2860
P304
P356
10.1158/0008-5472.CAN-10-1936
P407
P577
2010-10-12T00:00:00Z